EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Impact of Cannabidiol (CBD) on Lipid Absorption and Lymphatic Transport in Rats

Qi Zhu, Qing Yang, Ling Shen, Meifeng Xu, Min Liu iD

Nutrients · 2025

DOI: 10.3390/nu17061034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Qi Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45237, USA. Hauptthemen laut MEDLINE: Cannabidiol, Lipid Metabolism, Lymphatic System, Intestinal Absorption. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, JDRF, National Institutes of Health (United States).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cannabidiol (CBD) exerts diverse metabolic effects, yet its influence on intestinal lipid metabolism remains unclear.

Methods

In this study, we investigated whether short-term (one-week) CBD treatment affects lipid absorption and transport through the lymphatic system using a validated lymph fistula model.

Results

CBD treatment significantly enhanced the transport of radiolabeled triglycerides through the lymphatic system. This effect appeared specific, as CBD did not substantially alter cholesterol output in the lymph. Chemical assays indicated that CBD treatment did not significantly alter total triglycerides, cholesterol, phospholipids, or non-esterified fatty acid levels in the lymph. However, it significantly enhanced the lymphatic output of apolipoprotein A4 (ApoA4) and apolipoprotein A1 (ApoA1). Additionally, gene expression analysis revealed a downregulation of vascular endothelial growth factor receptor 1 (Flt1) in the small intestine, leading to increased lymphatic lacteal permeability and altered lipid transport dynamics.

Conclusions

These findings indicate that short-term CBD treatment modulates lymphatic lipid composition and apolipoprotein secretion by regulating lymphatic lacteal function, thereby influencing lipid transport and metabolism. This study provides novel insights into CBD’s role in facilitating TG-rich lipoprotein transport via the lymphatic system, highlighting its potential therapeutic applications in lipid-related disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolLipid MetabolismLymphatic SystemIntestinal AbsorptionAnimalsMaleRatsBiological TransportTriglyceridesRats, Sprague-DawleyApolipoprotein A-IApolipoproteins ALymphIntestine, Small

Stichwörter der Autor:innen

CBDapolipoproteinlipid absorption and transportlymph fistula model

Substanzen

CannabidiolTriglyceridesApolipoprotein A-Iapolipoprotein A-IVApolipoproteins A

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45237, USA.

ORCID-Profile: Min Liu

Förderung

  • NIH HHS
  • JDRF
  • National Institutes of Health (United States)

Zitieren

APA

Zhu, Q., Yang, Q., Shen, L., Xu, M., & Liu, M. (2025). The Impact of Cannabidiol (CBD) on Lipid Absorption and Lymphatic Transport in Rats. Nutrients. https://doi.org/10.3390/nu17061034

Vancouver

Zhu Q, Yang Q, Shen L, Xu M, Liu M. The Impact of Cannabidiol (CBD) on Lipid Absorption and Lymphatic Transport in Rats. Nutrients. 2025. doi:10.3390/nu17061034

BibTeX
@article{Zhu2025,
  author = {Zhu, Qi and Yang, Qing and Shen, Ling and Xu, Meifeng and Liu, Min},
  title = {The Impact of Cannabidiol (CBD) on Lipid Absorption and Lymphatic Transport in Rats},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17061034}
}
Kostenlos starten →